From June 19-21, the 22nd World Pharmaceutical Ingredients China Exhibition (CPHI China) and the 17th World Pharmaceutical Machinery, Packaging Equipment, and Materials China (PMEC China) kicked off at the Shanghai New International Expo Center. The event attracted over 60,000 professional buyers from more than 150 countries and regions, with a total attendance exceeding 90,000 industry colleagues. Together, they experienced the charm and vitality of the pharmaceutical industry!

Exhibition highlights

Fostering a new kind of competitiveness with innovation at its core
Showcasing groundbreaking innovations and visionary solutions at an event that brings together global expertise and cutting-edge technology

Solid Preparation Process Solution

The Mini-MD Multi-functional Fluidized Bed is equipped with easily interchangeable product pot modules, enabling multifunctional granulation, drying, and coating operations on a single machine. This ensures flexibility for product development and process improvement.

The Mini-WG wet granulator with smooth speed control provides precise parameters for operation; the switchable product pot module meets your needs for different throughputs in experiments.

API Process solution

The WD Multifunctional Filtration and Washing Dryer combines filtering, washing, and drying operations in a single unit. With simplified process flow and full-automatic control, it boosts production efficiency and minimizes pollution. The Solid Phase Peptide Synthesizer introduces innovative approaches to synthesizing and developing peptide drugs.







Total Laboratory Solutions

It offers upstream culture, downstream separation and purification, and single-use solutions to support customers' research and production, accelerating the implementation of innovations.











Furthermore, Morimatsu AB's extensive experience in delivering global modularized total plants, combined with the seamless integration of engineering and technology in the VR Simulation Training System, also captured the interest of many guests.





In the field of life and health, Morimatsu engages in exchanges with international friends and peers, leveraging specialized and global perspectives. They actively gather market demands and feedback, discuss collaborations, and seek mutual development.









The pharmaceutical industry is rapidly moving towards a new era of internationalization, digitalization, and personalization. Morimatsu views this exhibition as an opportunity to offer customers innovative and efficient products and solutions, aiming to establish a new business model in the global pharmaceutical industry and contribute to the health and well-being of humanity.

About Morimatsu LifeSciences

Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Company Limited, Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services.

As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacturing plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.

Forward-Looking Statements

The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of "predicted", "believed", "forecast", "planned" and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.

Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.